Cala Health, Inc. - Cala Health raises $50 Million in Series C funding investment that will fund the commercial introduction of Cala Trio and expansion of the therapeutic platform. Learn more at
![First Real-World Evidence Demonstrates Cala Trio's Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation | Business Wire First Real-World Evidence Demonstrates Cala Trio's Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation | Business Wire](https://mms.businesswire.com/media/20200914005095/en/820608/23/Cala+1.jpg)
First Real-World Evidence Demonstrates Cala Trio's Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation | Business Wire
![Covid-19. Ils conçoivent un bracelet distributeur de gel hydroalcoolique - Saint-Nazaire.maville.com Covid-19. Ils conçoivent un bracelet distributeur de gel hydroalcoolique - Saint-Nazaire.maville.com](https://maville.com/photosmvi/2020/11/09/P24045659D4368672G.jpg)
Covid-19. Ils conçoivent un bracelet distributeur de gel hydroalcoolique - Saint-Nazaire.maville.com
![Cala Health® on Twitter: "Exciting news from Cala Health: The #FDA has granted Breakthrough Device Designation to #CalaTrio for the treatment of action tremors in the hands of adults with #ParkinsonsDisease. Read Cala Health® on Twitter: "Exciting news from Cala Health: The #FDA has granted Breakthrough Device Designation to #CalaTrio for the treatment of action tremors in the hands of adults with #ParkinsonsDisease. Read](https://pbs.twimg.com/media/Ek8hJa4XgAAmYK5.jpg)